Abstract
In this review we describe the asymmetrization of readily available Cs-symmetric compounds by enzyme-catalyzed reactions to provide chiral building blocks for the effective enantioselective synthesis of certain indole and quinolizidine alkaloids. By the asymmetrization of 1,2-disubstituted cyclo cyclohex-4-enes a series of class I alkaloids, such as (-)-antirhine, (-)-akagerine, and (posative)-meroquinene, have been synthesized from the relevant chiral precursors. By employing the same chemo-enzymatic approach, asymmetrization of Cs-symmetric 3,5-disubstituted piperidines provides access to 15,20-dihydrocleavamine and its analogues, as well as to (posative)-tacamonine. The synthetic design and details of the various syntheses are presented. In addition, the scope and prospects of the symmetrization-asymmetrization strategy are discussed with special reference to the quinolizidine alkaloids.
Keywords: Quinolizidine alkaloids, Symmetric precursors, Class I Alkaloids, Antirhine, Antirhea putaminosa, Akagerine, Meroquinene, Intramolecular michael reactions, Indole alkaloids, Cs symmetric, 3,5 disubstituted, Tacamonine, Piperidines, Wittig or Wittig type, Swern oxidation, Parikh oxidation
Current Organic Chemistry
Title: A Chemo-Enzymatic Approach to Some Indole and Quinolizidine Alkaloids From Cs -Symmetric Precursors
Volume: 4 Issue: 2
Author(s): Bruno Danieli, Giordano Lesma, Daniele Passarella and Alessandra Silvani
Affiliation:
Keywords: Quinolizidine alkaloids, Symmetric precursors, Class I Alkaloids, Antirhine, Antirhea putaminosa, Akagerine, Meroquinene, Intramolecular michael reactions, Indole alkaloids, Cs symmetric, 3,5 disubstituted, Tacamonine, Piperidines, Wittig or Wittig type, Swern oxidation, Parikh oxidation
Abstract: In this review we describe the asymmetrization of readily available Cs-symmetric compounds by enzyme-catalyzed reactions to provide chiral building blocks for the effective enantioselective synthesis of certain indole and quinolizidine alkaloids. By the asymmetrization of 1,2-disubstituted cyclo cyclohex-4-enes a series of class I alkaloids, such as (-)-antirhine, (-)-akagerine, and (posative)-meroquinene, have been synthesized from the relevant chiral precursors. By employing the same chemo-enzymatic approach, asymmetrization of Cs-symmetric 3,5-disubstituted piperidines provides access to 15,20-dihydrocleavamine and its analogues, as well as to (posative)-tacamonine. The synthetic design and details of the various syntheses are presented. In addition, the scope and prospects of the symmetrization-asymmetrization strategy are discussed with special reference to the quinolizidine alkaloids.
Export Options
About this article
Cite this article as:
Danieli Bruno, Lesma Giordano, Passarella Daniele and Silvani Alessandra, A Chemo-Enzymatic Approach to Some Indole and Quinolizidine Alkaloids From Cs -Symmetric Precursors, Current Organic Chemistry 2000; 4 (2) . https://dx.doi.org/10.2174/1385272003376328
DOI https://dx.doi.org/10.2174/1385272003376328 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours
Current Cancer Drug Targets Physiology and Therapeutic Potential of the Thymic Peptide Thymulin
Current Pharmaceutical Design Dietary Fish Oil Reduces Colon Cancer Risk
Current Organic Chemistry Non Steroidal Anti-Inflammatory and Anti-Allergy Agents
Current Medicinal Chemistry Anti-Inflammatory/Analgesic
Current Bioactive Compounds Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Current Pharmaceutical Design Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC
Current Drug Discovery Technologies Sequential Therapy For Helicobacter pylori in Elderly Patients: Effectiveness, Safety and Predictors of Success
Letters in Drug Design & Discovery A Novel Functional Approach Toward Identifying Definitive Drug Targets
Current Medicinal Chemistry Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Possible Usefulness of Growth Hormone/Insulin-like Growth Factor-I Axis in Alzheimer’s Disease Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets Induction of Propranolol Metabolism by Ginkgo biloba Extract EGb 761 in Rats
Current Drug Metabolism Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer’s Disease: An LC-MS/MS-based Metabolomics Analysis
Current Alzheimer Research Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Neurorestorative Role of Stem Cells in Alzheimer’s Disease: Astrocyte Involvement
Current Alzheimer Research Supercritical Fluid Chromatographic Method for Montelukast: Application in Content Uniformity and Degradation Study
Current Analytical Chemistry Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Molluscum Contagiosum: An Update
Recent Patents on Inflammation & Allergy Drug Discovery